Login

FREE TRIAL  Receive 30 days of no-obligation access. SIGN UP

Home

Top Story

FTC Issues Controversial Breach Notification Rule Despite Two Commissioners’ Dissent

The Federal Trade Commission on Friday (April 26) finalized a controversial plan to extend the scope of its Health Breach Notification Rule to include personal health information collected by health apps and other technology that fall outside the Health Insurance Portability and Accountability Act, despite warnings from stakeholders the agency could be sued and dissenting opinions from two commissioners alleging FTC was overstepping its authority.

Bird Flu News

FDA, Industry Weigh Potential Pathway For Bird Flu Antigen Vaccine As Precaution

While still downplaying the potential risk to humans as testing continues after avian influenza was detected in 20% of milk sampled, administration officials Thursday (April 25) said FDA is working with industry on an appropriate regulatory pathway for rolling out vaccines made with that bulk antigen if necessary, and a vaccination prioritization plan based on responses to previous disease outbreaks is available if needed.

Latest News

CBO, Paragon Float Entitlement Reform Ideas

The Congressional Budget Office highlighted several health-related policies the agency estimates would save hundreds of billions of dollars from 2023-2033 -- like lowering federal pay for Medicaid, reforming Medicare Advantage benchmarks, increasing Medicare Part B premiums and limiting provider taxes -- during Thursday (April 25) presentation at a conservative think tank-sponsored event on entitlement reform.

GOP Calls For CMMI Cost Eval After CBO Finds Mixed ACO Savings

House Budget Committee Republicans are calling for an investigation into the Center for Medicare and Medicaid Innovation after a September Congressional Budget Office report highlighted mixed savings generated by accountable care organizations.

FDA Seeks Input On Ways To Update Clinical Pharmacology Policies

FDA is soliciting comments on what policy topics should be developed, prioritized or implemented by the drug center’s Office of Clinical Pharmacology (OCP) to promote effective research on drug development.

CBO Could Expand Budget Window For Hepatitis C Bill

The Congressional Budget Office (CBO) is looking at expanding its evaluation of the value of diagnosis and treatment of hepatitis C beyond a 10-year budget window, as it scores a bill expanding coverage for hep C treatment.